R Squared’s Gossamer Bio GOSS Stock Holding History

R Squared’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,360	Closed	-$3.04K	–	774
2024 Q4	$3.04K	Buy	+3,360	New	+$2.88K	﹤0.01%	1410

Other funds holding GOSS

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

R Squared's GOSS Position: Q1 2025 in Review

R Squared sold out of Gossamer Bio (GOSS) in Q1 2025, closing a stake of 3,360 shares — an estimated $3.04K sold.

R Squared first reported a position in GOSS in Q4 2024 and held it in 1 quarter. The position peaked at $3.04K in Q4 2024. 118 funds tracked by Wall St. Rank hold GOSS as of Q1 2025.

R Squared reported no remaining Gossamer Bio position as of Q1 2025 after selling out during the quarter.
R Squared sold 3,360 Gossamer Bio shares in Q1 2025, an estimated $3.04K.
R Squared first reported a position in Gossamer Bio in Q4 2024 and held it in 1 quarter.
R Squared's Gossamer Bio position peaked at $3.04K in Q4 2024.
118 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.